| Overview |
| bs-20315R-Cy5 |
| KCTD16 Polyclonal Antibody, Cy5 Conjugated |
| WB, IF(IHC-P), IF(IHC-F), IF(ICC) |
| Human |
| Mouse, Rat, Cow |
| Specifications |
| Cy5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human KCTD16 |
| 301-400/428 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 57528 |
| Q68DU8 |
| Cell membrane |
| BTB/POZ domain containing protein KCTD16; BTB/POZ domain-containing protein KCTD16; DKFZp781A1155; KCD16_HUMAN; KCTD16; KIAA1317; MGC138167; Potassium channel tetramerisation domain containing 16; Potassium channel tetramerization domain containing protein 16; Potassium channel tetramerization domain-containing protein 16; RGD1559856. |
| Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization. |
| Application Dilution |
| WB |
1:300-5000 |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |
Powered by Bioz